UCB, Inc.
UCB, Inc., a prominent biopharmaceutical company headquartered in the United States, has established itself as a leader in the development of innovative therapies for neurological and immunological disorders. Founded in 1928, UCB has achieved significant milestones, including the launch of groundbreaking treatments that address unmet medical needs. With a strong presence in North America and Europe, UCB focuses on core areas such as epilepsy, Parkinson's disease, and autoimmune conditions. Their unique approach combines advanced science with patient-centric solutions, setting them apart in the competitive biopharmaceutical landscape. Recognised for their commitment to research and development, UCB continues to enhance its market position through strategic partnerships and a robust pipeline of novel therapies.
DitchCarbon Score
How does UCB, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
UCB, Inc.'s score of 62 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
UCB, Inc.'s reported carbon emissions
UCB, Inc., headquartered in the US, currently does not provide specific carbon emissions data or reduction targets. Without available figures on their emissions, it is challenging to assess their climate impact or commitments. However, the company is expected to align with industry standards and best practices in addressing climate change. UCB, Inc. may be involved in initiatives aimed at reducing their carbon footprint, but specific details on their strategies or targets are not disclosed. As the global focus on sustainability intensifies, it is crucial for companies like UCB to establish clear climate commitments and transparent reporting on emissions to contribute effectively to climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
UCB, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
